Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Embryonic ectoderm development subunit (EED) is an essential scaffold protein within the Polycomb Repressive Complex 2 responsible for reading repressive chromatin marks and maintaining transcriptional silencing during development. Its disruption leads to profound developmental defects or disease states including cancer—making it an important target for therapeutic intervention using small molecule inhibitors designed specifically against its substrate-binding domain.
Disruption of PRC2 function by competitively binding at the substrate recognition site on EED
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Embryonic Ectoderm Development Subunit (EED).